These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12667182)

  • 1. In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood.
    Rickards KJ; Page CP; Lees P; Gettinby G; Cunningham FM
    J Vet Pharmacol Ther; 2003 Apr; 26(2):123-30. PubMed ID: 12667182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors.
    Rickards KJ; Page CP; Lees P; Cunningham FM
    J Vet Pharmacol Ther; 2001 Aug; 24(4):275-81. PubMed ID: 11555183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
    Tang HF; Lu JJ; Tang JF; Zheng X; Liang YQ; Wang XF; Wang YJ; Mao LG; Chen JQ
    Int Immunopharmacol; 2010 Apr; 10(4):406-11. PubMed ID: 20074667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
    Wollin L; Bundschuh DS; Wohlsen A; Marx D; Beume R
    Pulm Pharmacol Ther; 2006; 19(5):343-52. PubMed ID: 16257550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
    Ouagued M; Martin-Chouly CA; Brinchault G; Leportier-Comoy C; Depincé A; Bertrand C; Lagente V; Belleguic C; Pruniaux MP
    Pulm Pharmacol Ther; 2005; 18(1):49-54. PubMed ID: 15607127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
    Harada D; Tsukumo Y; Takashima Y; Manabe H
    Eur J Pharmacol; 2006 Feb; 532(1-2):128-37. PubMed ID: 16442096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
    Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
    Souza DG; Cassali GD; Poole S; Teixeira MM
    Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.
    Cooper N; Teixeira MM; Warneck J; Miotla JM; Wills RE; Macari DM; Gristwood RW; Hellewell PG
    Br J Pharmacol; 1999 Apr; 126(8):1863-71. PubMed ID: 10372831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses.
    Lavoie JP; Pasloske K; Joubert P; Cordeau ME; Mancini J; Girard Y; Friesen RW; Frenette R; Blouin M; Young RN; Hickey G
    J Vet Intern Med; 2006; 20(1):175-81. PubMed ID: 16496938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between phosphodiesterase type 4 inhibition and anti-inflammatory activity of CI-1044 in rat airways.
    Pruniaux MP; Lagente V; Ouaged M; Bertin B; Moreau F; Julien-Larose C; Rocher MN; Leportier C; Martin B; Bouget A; Dubuit JP; Burnouf C; Doherty AM; Bertrand CP
    Fundam Clin Pharmacol; 2010 Feb; 24(1):73-82. PubMed ID: 19650853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.
    Miotla JM; Teixeira MM; Hellewell PG
    Am J Respir Cell Mol Biol; 1998 Mar; 18(3):411-20. PubMed ID: 9490659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase activity in neutrophils from horses with chronic obstructive pulmonary disease.
    Rickards KJ; Page CP; Lees P; Cunningham FM
    Vet Immunol Immunopathol; 2000 Oct; 76(3-4):319-30. PubMed ID: 11044563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
    Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
    Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of phosphodiesterase inhibitor, rolipram, on hemodynamics in lipopolysaccharide-treated rats.
    Dutta P; Ryan DE; Tabrizchi R
    Jpn J Pharmacol; 2001 Mar; 85(3):241-9. PubMed ID: 11325016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
    Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
    J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294.
    Gale DD; Hofer P; Spina D; Seeds EA; Banner KH; Harrison S; Douglas G; Matsumoto T; Page CP; Wong RH; Jordan S; Smith F; Banik N; Halushka PV; Cavalla D; Rotshteyn Y; Kyle DJ; Burch RM; Chasin M
    Pulm Pharmacol Ther; 2003; 16(2):97-104. PubMed ID: 12670778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
    Makhay MM; Houslay MD; O'Donnell JM
    Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.